[HTML][HTML] Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone Research, 2021 - nature.com
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone Research, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Ankylosing spondylitis (AS) is chronic
inflammatory arthritis with a progressive fusion of axial joints. Anti-inflammatory treatments …
inflammatory arthritis with a progressive fusion of axial joints. Anti-inflammatory treatments …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai… - Bone …, 2021 - pubmed.ncbi.nlm.nih.gov
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone …, 2021 - pure.johnshopkins.edu
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - 2021 - agris.fao.org
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
[HTML][HTML] Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone …, 2021 - ncbi.nlm.nih.gov
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification.
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone …, 2021 - europepmc.org
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
[PDF][PDF] Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - 2021 - medenos.com
Ankylosing spondylitis (AS) is an autoimmune disease that mainly affects the spine and
sacroiliac joint with a progressive increase in the stiffness of soft tissues, including …
sacroiliac joint with a progressive increase in the stiffness of soft tissues, including …
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
T Yu, J Zhang, W Zhu, X Wang, B Yun, B Feng… - Bone …, 2021 - search.proquest.com
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …